Effects of FDA advisories on the pharmacologic treatment of ADHD, 2004-2008. [electronic resource]
Producer: 20130920Description: 339-46 p. digitalISSN:- 1557-9700
- Adolescent
- Adrenergic Uptake Inhibitors -- therapeutic use
- Adrenergic alpha-2 Receptor Agonists -- therapeutic use
- Amphetamines -- therapeutic use
- Atomoxetine Hydrochloride
- Attention Deficit Disorder with Hyperactivity -- drug therapy
- Bupropion -- therapeutic use
- Central Nervous System Stimulants -- therapeutic use
- Child
- Clonidine -- therapeutic use
- Dopamine Uptake Inhibitors -- therapeutic use
- Drug Utilization
- Guanfacine -- therapeutic use
- Humans
- Practice Patterns, Physicians' -- statistics & numerical data
- Propylamines -- therapeutic use
- United States
- United States Food and Drug Administration
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.